ARS Pharmaceuticals, Inc.
For the period ended Jun 25, 2025. Filed Apr 29, 2025.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Jun 25, 2025 · Filed Apr 29, 2025
Use the contents to explore the available documents and sections.
Contents
Not Applicable
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box)
☒ No fee required
☐ Fee paid previously with preliminary materials
☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11
11682 El Camino Real, Suite 120
San Diego, California 92130
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.